Schrodinger said on Friday it is collaborating with Eli Lilly to offer the pharmaceutical major's AI-based platform, TuneLab, ...

The project was secured by a Jobs, Energy, Technology and Innovation Act (JETI) tax agreement, which includes a school tax ...

Eli Lilly and Company (NYSE:LLY) is one of the best performing pharma stocks in 2025. Eli Lilly and Company (NYSE:LLY) ...

The big lure for Eli Lilly to build a $6.5 billion pharmaceuticals plant in Houston is now official — and details are out on ...

The about-$1 billion deal could come imminently.

An approval of Lilly's pill, along with its current strength in the weight loss market, could equal revenue growth well into ...

BRANCHBURG – Korean pharmaceutical firm Celltrion has launched operations at the former Eli Lilly facilities on Imclone Drive ...

Schrödinger (SDGR) stock and Revvity (RVTY stock are in focus as firms join Eli Lilly (LLY) to integrate their software with ...

The lawsuit alleges insulin can cost Eli Lilly just a few dollars to produce, while some consumers are charged hundreds of ...

Aktis Oncology Inc. shares jumped 24 percent in their trading debut after the clinical-stage biotechnology company raised ...

Attorney General Todd Rokita is intensifying his efforts to lower insulin prices and improve healthcare affordability for ...

Eli Lilly and Company rated Buy: incretin/obesity growth, ZEPBOUND & orforglipron access strategy, pipeline deals, ...